HIV prevention efforts, including vaccine, microbicide and co-infection prophylaxis strategies, have yielded disappointing results, highlighting the need for new concepts. To this end, a better understanding of early events in HIV infection, including HIV acquisition in the face of an existing HIV infection (superinfection) are needed. Superinfection, in particular, offers an opportunity to examine immune correlates of protection based on responses to the initial infection. Our research team is in unique position to address such questions because we have developed and maintained a cohort of ~ 2000 women at high-risk of HIV infection for the past 15 years. This cohort includes more than 300 women who have known dates of HIV infection and who have been followed closely, including regular sample collection for a median of 4.4 years after their infection. Importantly, 12 cases of superinfection were identified in the first 56 women examined in this cohort, including both intra and intersubtype re-infections. Here we propose to continue monitoring this unique cohort and leveraging existing samples to examine factors that influence early virus control and the incidence of superinfection and its correlates. Specifically, we propose to examine the role of early humoral immune responses, particularly antibodies that contribute to Fc-mediated antibody activity, in viral control and disease progression. We propose to examine the role of these same immune parameters in cases of superinfection to determine if there are deficits in humoral immunity in those who become superinfected. A major emphasis of our studies will be in determining whether a first HIV infection provides any protection from a second infection by determining if the incidence of superinfection is lower that the incidence of initial infection. We propose to examine whether there are cases of transient superinfection, and if so, whether antibody responses may play a role in viral control in this setting. Together, these studies will provide critical data on the role of Fc-mediated antibody activity in defining early virus control and subsequent disease as well as their potential role in protection from infection.

Public Health Relevance

These studies will help determine whether the host response to natural HIV infection provides any protection against subsequent infection. The studies are also designed to define the nature of any protective humoral immune response, if present, with the goal of using such information to inform future vaccine and prevention strategies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
2R37AI038518-16A2
Application #
7926850
Study Section
AIDS Immunology and Pathogenesis Study Section (AIP)
Program Officer
Sharma, Opendra K
Project Start
1995-09-15
Project End
2015-02-28
Budget Start
2010-03-01
Budget End
2011-02-28
Support Year
16
Fiscal Year
2010
Total Cost
$840,402
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Williams, Katherine L; Wang, Bingjie; Arenz, Dana et al. (2018) Superinfection Drives HIV Neutralizing Antibody Responses from Several B Cell Lineages that Contribute to a Polyclonal Repertoire. Cell Rep 23:682-691
Roberts, Sarah T; Flaherty, Brian P; Deya, Ruth et al. (2018) Patterns of Gender-Based Violence and Associations with Mental Health and HIV Risk Behavior Among Female Sex Workers in Mombasa, Kenya: A Latent Class Analysis. AIDS Behav 22:3273-3286
Heffron, Renee; McClelland, R Scott; Balkus, Jennifer E et al. (2017) Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study. Lancet HIV 4:e449-e456
Ronen, Keshet; Dingens, Adam S; Graham, Susan M et al. (2017) Comprehensive Characterization of Humoral Correlates of Human Immunodeficiency Virus 1 Superinfection Acquisition in High-risk Kenyan Women. EBioMedicine 18:216-224
Doria-Rose, Nicole A; Altae-Tran, Han R; Roark, Ryan S et al. (2017) Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting. PLoS Pathog 13:e1006148
LaCourse, Sylvia M; Deya, Ruth W; Graham, Susan M et al. (2017) Evaluation of the Isoniazid Preventive Therapy Care Cascade Among HIV-Positive Female Sex Workers in Mombasa, Kenya. J Acquir Immune Defic Syndr 76:74-81
Boyd, David F; Sharma, Amit; Humes, Daryl et al. (2016) Adapting SHIVs In Vivo Selects for Envelope-Mediated Interferon-? Resistance. PLoS Pathog 12:e1005727
Sanders, Eduard J; Wahome, Elizabeth; Powers, Kimberly A et al. (2015) Targeted screening of at-risk adults for acute HIV-1 infection in sub-Saharan Africa. AIDS 29 Suppl 3:S221-30
Masese, Linnet; Baeten, Jared M; Richardson, Barbra A et al. (2015) Changes in the contribution of genital tract infections to HIV acquisition among Kenyan high-risk women from 1993 to 2012. AIDS 29:1077-85
Weis, Julie F; McClelland, R Scott; Jaoko, Walter et al. (2015) Short communication: Fc gamma receptors IIa and IIIa genetic polymorphisms do not predict HIV-1 disease progression in Kenyan women. AIDS Res Hum Retroviruses 31:288-92

Showing the most recent 10 out of 88 publications